Heparin‐binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Cellular Biochemistry

• Publication date

  1996-09-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/(SICI)1097-4644(19960915)62:4<431::AID-JCB1>3.0.CO;2-NPMID 8891889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin (*)

  1996cited by this paper
• Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells.

  1995cited by this paper
• Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis.

  1995cited by this paper
• Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

  1994cited by this paper
• Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.

  1994cited by this paper
• Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

  1994cited by this paper
• Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.

  1994cited by this paper
• Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.

  1994cited by this paper
• Thrombospondins.

  1994cited by this paper
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth.

  1993cited by this paper
• Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin‐binding domain and synthetic peptides from the type I repeats of thrombospondin

  1993cited by this paper
• The functions of thrombospondin and its involvement in physiology and pathophysiology.

  1993cited by this paper
• Involvement of thrombospondin in the adherence of human breast‐adenocarcinoma cells: A possible role in the metastatic process

  1993cited by this paper
• Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain

  1993cited by this paper
• Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.

  1993cited by this paper
• Diverse mechanisms for cell attachment to platelet thrombospondin.

  1993cited by this paper
• Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.

  1993cited by this paper
• Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins.

  1993cited by this paper
• Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation.

  1992cited by this paper
• Thrombospondin Levels in Patients with Malignancy

  1992cited by this paper
• Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.

  1992cited by this paper
• Induction of thrombospondin 1 by retinoic acid is important during differentiation of neuroblastoma cells.

  1992cited by this paper
• Expression and mutagenesis of thrombospondin.

  1992cited by this paper
• Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin

  1992cited by this paper
• Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding.

  1992cited by this paper
• Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion.

  1992cited by this paper
• Thrombospondins.

  1991cited by this paper
• The properdin-like type I repeats of human thrombospondin contain a cell attachment site

  1991cited by this paper
• Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma.

  1991cited by this paper
• A quantitative microwell assay for chondrocyte cell adhesion.

  1991cited by this paper
• Thrombospondin-induced adhesion of human platelets.

  1991cited by this paper
• Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.

  1991cited by this paper
• Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.

  1991cited by this paper
• Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.

  1991cited by this paper
• Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.

  1991cited by this paper
• Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.

  1990cited by this paper
• A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

  1990cited by this paper
• Thrombospondin deposition in rat carotid artery injury.

  1990cited by this paper
• Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells.

  1990cited by this paper
• The GPIIB-IIIa-like complex may function as a human melanoma cell adhesion receptor for thrombospondin.

  1989cited by this paper
• EGF‐like domains in extracellular matrix proteins: Localized signals for growth and differentiation?

  1989cited by this paper
• Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells.

  1988cited by this paper
• Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors

  1988cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo

  1988cited by this paper
• Thrombospondin, a potentiator of tumor cell metastasis.

  1987cited by this paper
• Thrombospondin promotes cell-substratum adhesion.

  1987cited by this paper
• Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains

  1987cited by this paper
• Interactions of thrombospondin with endothelial cells: receptor- mediated binding and degradation

  1987cited by this paper
• Chlorate--a potent inhibitor of protein sulfation in intact cells.

  1986cited by this paper
• Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

  1986cited by this paper
• The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins

  1986cited by this paper
• A simple, rapid, and sensitive DNA assay procedure.

  1980cited by this paper

• Members of the thrombospondin gene family bind stromal interaction molecule 1 and regulate calcium channel activity

  2014cites this paper
• Estrogen regulation of thrombospondin‐1 in human breast cancer cells

  2009cites this paper
• A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds.

  2007cites this paper
• Shear Stress Induced Release of Von Willebrand Factor and Thrombospondin-1 in Uvec Extracellular Matrix Enhances Breast Tumour Cell Adhesion

  2005cites this paper
• Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists.

  2004cites this paper
• Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: Effects of αvβ3 and αIIbβ3 antagonists

  2004cites this paper
• BIOCHEMICAL CHARACTERIZATION AND ACTION OF CONNECTIVE TISSUE GROWTH FACTOR AND ITS RECEPTOR IN CORNEAL SCARRING

  2003cites this paper
• Human lung mast cell and eosinophil adhesion to bronchial epithelium

  2001cites this paper
• The N-terminal of thrombospondin-1 is essential for coagulase-negative staphylococcal binding.

  2001cites this paper
• Diverse mechanisms of osteoblast spreading on hydroxyapatite and titanium.

  2000cites this paper
• Thrombospondin‐1/HIV‐1 Tat protein interaction: modulation of the biological activity of extracellular Tat

  2000cites this paper
• Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate‐mediated mechanism

  2000influential citation
• Transforming growth factor-beta 1 increases the adhesion of MDA-MB-231 mammary adenocarcinoma cells to the microvascular subendothelium.

  1999cites this paper
• Pseudoachondroplastic dysplasia: an Iowa review from human to mouse.

  1999cites this paper
• Increased adhesion of the promyelocytic leukaemia cell line, NB4, to fibronectin and thrombospondin upon all‐trans‐retinoic acid treatment

  1999cites this paper
• Interaction of Recombinant Procollagen and Properdin Modules of Thrombospondin-1 with Heparin and Fibrinogen/Fibrin*

  1999cites this paper
• Pro-adhesive and Chemotactic Activities of Thrombospondin-1 for Breast Carcinoma Cells Are Mediated by α3β1 Integrin and Regulated by Insulin-like Growth Factor-1 and CD98*

  1999cites this paper
• Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin.

  1999cites this paper
• Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein.

  1999cites this paper
• Thrombospondin is Sequentially Expressed and then De-expressed During Early Pregnancy in the Rat Uterus

  1999cites this paper